Mrs. Snezana Mugosa, Institute for Medicines and Medical Devices, Montenegro
Dr. Snežana Mugoša is a distinguished medical professional and regulatory authority in the field of pharmacology and clinical trials. She currently serves as the Managing Director of the Institute for Medicines and Medical Devices of Montenegro (CInMED), while also holding an academic appointment as Assistant Professor at the Medical Faculty, University of Montenegro. With two decades of clinical and regulatory experience, she is recognized for her expertise in pharmacotherapy, adverse drug reaction assessment, and regulatory science. Her work extends across policy, academia, and international scientific collaboration, establishing her as a leader in pharmacovigilance and drug safety.
🌍 Professional Profile
Scopus
🏆 Suitability for Best Researcher Award
Snežana Mugoša appears to be highly qualified for the Research for Best Researcher Award, based on her extensive background in clinical pharmacology, pharmacotherapy, and pharmacovigilance, as well as her significant involvement in research, education, and management.
🎓 Education
Dr. Mugoša holds a strong academic foundation, beginning with her medical degree from the Medical Faculty in Podgorica in 2004, where she graduated with the highest average in her class. She later earned a Master’s degree in Clinical Pharmacology and Therapy in 2009 and completed her specialization in Internal Medicine in 2011. She received her PhD in Clinical Pharmacology in 2015 with a thesis focused on risk factors for adverse drug reactions in cardiac patients. Most recently, she completed a subspecialization in Pharmacology and Pharmacotherapy at the University of Belgrade in 2025, earning top marks. Her academic achievements are further complemented by fluency in multiple languages and advanced computer literacy.
💼 Experience
Over her career, Dr. Mugoša has held a wide array of clinical, academic, and regulatory roles. She has been with CInMED since 2012, where she served as the Head of Clinical Trials and later Deputy Director before becoming Managing Director in 2022. Parallel to her regulatory duties, she has taught clinical pharmacy and pharmacological subjects at the University of Montenegro since 2004, becoming an Assistant Professor in 2021. Her clinical foundation was built during her time as an internal medicine specialist at the Clinical Centre of Montenegro and as a resident and intern in Podgorica. Additionally, she is a long-standing lecturer at the Clinical Research Academy in Belgrade.
🔬 Research Focus
Her scientific focus lies in clinical pharmacology, pharmacotherapy, pharmacoepidemiology, and pharmacogenetics, with a deep interest in adverse drug reactions, their genetic correlations, and clinical trials. She has actively participated in international research collaborations, including EU-funded COST Actions and Erasmus+ projects. Her work not only enriches the academic community but also contributes directly to improving patient safety and regulatory standards for medical products.
📚 Publication Top Notes
Artificial Intelligence Strategies Based on Random Forests for Detection of AI-Generated Content in Public Health
Authors: I.V. Pantić, Igor V., S. Mugoša, Snežana
Journal: Public Health, 2025
This study explores the use of random forest algorithms to detect AI-generated content in public health communication. It highlights how AI can help differentiate between human-authored and machine-generated health information, ensuring authenticity in public health messaging. The model demonstrated high accuracy, making it a promising tool for improving content integrity in public health sectors.
Exploring Pet Owners’ Attitudes Toward Compounded and Human-Approved Medicines: A Questionnaire-Based Pilot Study
Authors: Z. Kovaĉević, Zorana; D. Tomanić, Dragana; L.Ć. Šarić, Ljubiša Ć.; D. Novaković, Dragana; O.J. Horvat, Olga J.; S. Mugoša, Snežana
Journal: Veterinary Research Communications, 2025
This pilot study investigates pet owners’ perceptions and knowledge about compounded versus human-approved medicines. The findings reveal significant gaps in understanding, with many pet owners unaware of the regulatory differences and risks. The research underscores the need for better education and clearer regulations in veterinary medicine.